This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Oct 2010

Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2

President and Chief Executive Officer John L. Higgins will present at the Oppenheimer 21st Annual Healthcare Conference on November 2.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that President and Chief Executive Officer John L. Higgins will present at the Oppenheimer 21st Annual Healthcare Conference on Tuesday, November 2, 2010 at 9:40 a.m. Eastern time (6:40 a.m. Pacific). The conference takes place at the Waldorf Astoria in New York.

A live webcast of the presentation will be available on the Company's website www.ligand.com. A replay of the presentation will be archived on the site for 30 days.

About Ligand Pharmaceuticals

Ligand discovers and develops novel drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's disease, dyslipidemia, diabetes, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based assays, tissue-specific receptor ligand intera

Related News